semaglutide patent date expiry in India to trigger a wave of cheaper generics Novo Nordisk to lose blockbuster

Before we continue, its important to check with your doctor before making any changes to your dosing schedule

However, it is important to note that the drug does not have FDA approval for weight management

and (3) "No, and I do not plan to take them." Figure 1 shows that 11.8 percent of adults reported using GLP-1 agonists in 2025 about the same percentage of users reported in 2023 by KFF

Increased Caloric Burn : It can slightly increase energy expenditure, which supports weight loss efforts

A typical day on GLP-1 might look like a small breakfast, a light lunch, and a modest dinner with very little hunger prompting you to eat more